These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20805673)

  • 1. [Molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria: a role of NKG2D-medicated immunity].
    Kawaguchi T
    Rinsho Ketsueki; 2010 Aug; 51(8):664-71. PubMed ID: 20805673
    [No Abstract]   [Full Text] [Related]  

  • 2. NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes.
    Hanaoka N; Nakakuma H; Horikawa K; Nagakura S; Tsuzuki Y; Shimanuki M; Kojima K; Yonemura Y; Kawaguchi T
    Br J Haematol; 2009 Sep; 146(5):538-45. PubMed ID: 19594748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupancy of whole blood cells by a single PIGA-mutant clone with HMGA2 amplification in a paroxysmal nocturnal haemoglobinuria patient having blood cells with NKG2D ligands.
    Hanaoka N; Murakami Y; Nagata M; Horikawa K; Nagakura S; Yonemura Y; Murata S; Sonoki T; Kinoshita T; Nakakuma H
    Br J Haematol; 2013 Jan; 160(1):114-6. PubMed ID: 23078078
    [No Abstract]   [Full Text] [Related]  

  • 4. [Paroxysmal nocturnal hemoglobinuria: mechanism of clonal expansion].
    Kinoshita T; Murakami R; Inoue T
    Rinsho Ketsueki; 2005 May; 46(5):317-23. PubMed ID: 16444964
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):333-46. PubMed ID: 19327587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killer immunoglobulin-like receptor genotype in immune-mediated bone marrow failure syndromes.
    Howe EC; Wlodarski M; Ball EJ; Rybicki L; Maciejewski JP
    Exp Hematol; 2005 Nov; 33(11):1357-62. PubMed ID: 16263420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene mutations in bone marrow failure syndromes].
    Yoshizato T; Makishima H
    Rinsho Ketsueki; 2016; 57(12):2519-2525. PubMed ID: 28090021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The content of lymphopoietic differentiation antigens on the membrane of blood lymphoid cells in patients with bone marrow hypoplasia studied using monoclonal antibodies].
    Miterev GIu; Novikova MS; Bulycheva TI; Turbina NS; Mikhaĭlova EA
    Gematol Transfuziol; 1988 Oct; 33(10):10-5. PubMed ID: 3265120
    [No Abstract]   [Full Text] [Related]  

  • 9. [Paroxysmal nocturnal hemoglobinuria (PNH). Pathogenesis, diagnosis and treatment].
    Röth A; Dührsen U; Schrezenmeier H; Schubert J
    Dtsch Med Wochenschr; 2009 Feb; 134(9):404-9. PubMed ID: 19224425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia.
    Sun W; Wu Z; Lin Z; Hollinger M; Chen J; Feng X; Young NS
    Blood; 2018 Dec; 132(26):2730-2743. PubMed ID: 30361263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Clonal Mutations in Bone Marrow Failure and Inherited Myelodysplastic Syndrome/Acute Myeloid Leukemia Predisposition Syndromes.
    Schaefer EJ; Lindsley RC
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):643-655. PubMed ID: 30047417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.
    van Bijnen ST; Withaar M; Preijers F; van der Meer A; de Witte T; Muus P; Dolstra H
    Exp Hematol; 2011 Jul; 39(7):751-62.e1-3. PubMed ID: 21554925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology and treatment of paroxysmal nocturnal hemoglobinuria (PNH)--recent advances].
    Shichishima A; Shichishima T;
    Rinsho Ketsueki; 2009 Dec; 50(12):1679-86. PubMed ID: 20068274
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonal origin of abnormal granulocytes in paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hillmen P; Luzzatto L
    Blood; 1992 Aug; 80(3):844-5. PubMed ID: 1638035
    [No Abstract]   [Full Text] [Related]  

  • 15. Paroxysmal nocturnal hemoglobinuria: current issues in pathophysiology and treatment.
    Young NS
    Curr Hematol Rep; 2005 Mar; 4(2):103-9. PubMed ID: 15720958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse reactions and medical approach to paroxysmal nocturnal hemoglobinuria.
    Colombo GM; Guglielmelli E; Sacco T; Cicchinelli M
    Minerva Med; 2007 Feb; 98(1):87-8. PubMed ID: 17372586
    [No Abstract]   [Full Text] [Related]  

  • 17. Paroxysmal nocturnal hemoglobinuria clones are not infrequent in patients with inherited bone marrow failure syndromes.
    Sreedharanunni S; Varma N; Sachdeva MUS; Naseem S; Malhotra P; Bansal D; Sood A; Bose P; Varma S
    Eur J Haematol; 2017 Aug; 99(2):194-195. PubMed ID: 28452421
    [No Abstract]   [Full Text] [Related]  

  • 18. Eculizumab in paroxysmal nocturnal hemoglobinuria.
    Takita M; Matsumura T; Kami M
    N Engl J Med; 2006 Dec; 355(26):2787; author reply 2787-8. PubMed ID: 17193722
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: IV. recent topics of hematopoiesis; 3. Immune-associated bone marrow failure syndromes and target molecules].
    Nakakuma H
    Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):2010-5. PubMed ID: 22897006
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatic Mutations in Aplastic Anemia.
    Mufti GJ; Marsh JCW
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):595-607. PubMed ID: 30047413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.